| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Immunitybio, Inc. (IBRX) has 10 insiders with recent SEC Form 4 filings, including 4 buys and 15 sells. IBRX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 29.82M | $253.77M | - | |
| CEO | 548.2K | $4.67M | - | |
| CFO | 322.8K | $2.75M | - | |
| Dir | 162.8K | $1.39M | - | |
| Dir | 162.8K | $1.39M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 13, 2017 | Gorlin Steve | Director | Sell | 39,604 | $5.93 | $234,728.95 | -13.9% | |
| Sep 12, 2017 | Gorlin Steve | Director | Sell | 103,841 | $6.04 | $627,417.30 | -9.6% | |
| Jun 20, 2017 | Thomas John C | Director | Sell | 40,000 | $7.46 | $298,500.00 | -4.4% | |
| Jun 20, 2017 | Gorlin Steve | Director | Sell | 40,000 | $7.78 | $311,200.00 | -4.8% | |
| Nov 25, 2016 | Thomas John C | Director | Sell | 6,168 | $7.50 | $46,260.00 | -2.0% | |
| Nov 23, 2016 | Thomas John C | Director | Sell | 20,000 | $7.50 | $150,000.00 | -3.0% | |
| Sep 8, 2016 | Simon Barry J.79 | President And COO | Sell | 32,000 | $7.49 | $239,671.20 | -0.9% | |
| Jul 7, 2016 | Soon-Shiong Patrick | Chairman And CEO | Buy | 5,618,326 | $0.00 | - | New | |
| Dec 10, 2015 | Wilson Angela | Chief Financial Officer | Buy | 3,265 | $15.33 | $50,042.58 | +796.3% | |
| Aug 21, 2015 | Gorlin Steve | Director | Sell | 450,000 | $23.00 | $10,350,000.00 | -67.0% |